Search

everythinglearnresearchcommunity

for

Search:↓

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

CRISPR-based tools improve understanding and treatment of skin development and conditions.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

Understanding how acne develops in different diseases could lead to new treatments.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Wnt-activating drugs generally do not increase cancer risk.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Targeting and modifying the stem cell niche can improve regenerative therapies.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Thymosin β4 helps in cell activities, healing, and organ preservation, and treats hair loss and skin injuries.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

IGF-1 can help regrow hair and may be a promising treatment for hair loss.

Epidermal nevi are skin cell clusters linked to various syndromes.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Sparse hairs below frontal hairline can indicate early male balding.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.